Oxford Immunotec Reports Second Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
Oxford Immunotec (OXFD) Reports In-Line Q2 EPS
July 31, 2018 7:06 AM EDTOxford Immunotec (NASDAQ: OXFD) reported Q2 EPS of ($0.25), in-line with the analyst estimate of ($0.25). Revenue for the quarter came in at $29.3 million versus the consensus estimate of $28.55 million.
For earnings history and earnings-related data on Oxford Immunotec (OXFD) click here.
... More